TELIX PHARMACEUTICALS LIMITED

3.29%

$25.56

Market Cap $8.645B

Healthcare Biotechnology

Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on... Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.More

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care. WEBINAR: What investors should know about what it takes for ASX-listed companies to get medical developments...

Latest Threads

Tag

Subject

TLX

Telix ASX TLX Breaking News & Current Commentary

47 48 49

11:19

2.8K

1.1M

11:19

Last post mnbvcxz12345

2.8K

1.1M

TLX

Ann: Notification regarding unquoted securities - TLX

05/06/25

240

05/06/25

Last post

ASX News

240

TLX

Ann: Application for quotation of securities - TLX

05/06/25

209

05/06/25

Last post

ASX News

209

TLX

Ann: Notification regarding unquoted securities - TLX

05/06/25

259

05/06/25

Last post

ASX News

259

TLX

Ann: Notification regarding unquoted securities - TLX

05/06/25

219

05/06/25

Last post

ASX News

219

TLX

Ann: Telix Results of Annual General Meeting

23/05/25

5.3K

23/05/25

Last post mnbvcxz12345

5.3K

TLX

Ann: App 3Z Final Director Interests - K McCann

22/05/25

490

22/05/25

Last post

ASX News

490

TLX

Ann: Telix Annual General Meeting Presentation

21/05/25

626

21/05/25

Last post

ASX News

626

See All Discussions

Timeline

Notification regarding unquoted securities - TLX
05 Jun 08:23	Share

Application for quotation of securities - TLX
05 Jun 08:23	Share

Notification regarding unquoted securities - TLX
05 Jun 08:23	Share

Notification regarding unquoted securities - TLX
05 Jun 08:23	Share

App 3Z Final Director Interests - K McCann
22 May 08:19	Share

Telix Results of Annual General Meeting
21 May 14:43	Share

Telix Annual General Meeting Presentation
21 May 10:03	Share

Telix Annual General Meeting Chairman and CEO Addresses
21 May 10:02	Share

Pending Release of Shares from Voluntary Escrow
19 May 08:23	Share

Application for quotation of securities - TLX
16 May 17:37	Share

Notification of cessation of securities - TLX
16 May 17:30	Share

Notification regarding unquoted securities - TLX
09 May 08:30	Share

Cleansing Notice
06 May 08:21	Share

Application for quotation of securities - TLX
06 May 08:21	Share

App 3Z Final Director Interests - A Whitaker
01 May 09:12	Share

Anne Whitaker Board Resignation
29 Apr 08:26	Share

Telix Provides Regulatory Update on TLX101-CDx
28 Apr 08:33	Share

Pending Release of Shares from Voluntary Escrow
24 Apr 08:20	Share

Telix Reports US$186M Q1 Revenue, Up 62% YOY
22 Apr 17:01	Share

Pending Release of Shares from Voluntary Escrow
22 Apr 08:22	Share

Telix Notice of AGM, Proxy Form and Online Guide
17 Apr 08:24	Share

IPAX-Linz Promising Efficacy for TLX101 Glioma Tx Candidate
16 Apr 08:20	Share

Change of Registry Address Notification
14 Apr 16:48	Share

Telix Responds to Recent U.S. Government Actions
07 Apr 13:37	Share

App 3X Initial Director Interests - A Whitaker
04 Apr 08:22	Share

Anne Whitaker Appointed as Non-Executive Director
04 Apr 08:21	Share

Notification of cessation of securities - TLX
03 Apr 09:18	Share

Application for quotation of securities - TLX
03 Apr 09:18	Share

Pending Release of Shares from Voluntary Escrow
03 Apr 09:08	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $25.56		Change -0.870(3.29%)		Mkt cap ! $8.645B

Open	High	Low	Value	Volume
$26.70	$26.84	$25.56	$16.61M	640.1K

Buyers (Bids)

No.	Vol.	Price($)
2	891	$25.54

Sellers (Offers)

Price($)	Vol.	No.
$25.73	6596	1

View Market Depth

No.	Vol.	Price($)
2	10046	25.510
5	1510	25.500
1	20	25.470
1	1000	25.400
2	6000	25.310

Price($)	Vol.	No.
25.770	136	1
25.950	3000	1
26.140	200	1
26.190	192	1
26.200	1804	2

Last trade - 16.10pm 06/06/2025 (20 minute delay)

TLX (ASX) Chart

TELIX PHARMACEUTICALS LIMITED

Latest Threads

Timeline

Featured News

Latest Articles

Telix dips as FDA knocks back new drug for imaging rare brain cancer – despite prior approval

Telix copped a sharp jab on Monday as the FDA said its drug TLX101-CDx can't be accepted for imaging the rare brain cancer glioma.

Telix clocks +150% year-on-year returns as radiopharma acquisition well received

Telix Pharmaceuticals (ASX:TLX) has joined a somewhat quiet cohort of ASX biotech companies having a pretty good run lately.

Telix takes on 'next-gen' cancer drug candidates through $372m asset buy

Telix Pharmaceuticals Ltd has entered an asset purchase agreement with antibody engineering company ImaginAb, Inc

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News